Galapagos | GLPG - Ebit

Preço das Ações
24.52
Mudança Diária
0.20 0.82%
Mensal
-0.49%
Anual
6.42%
Q2 Previsão
23.62




Ebit Alterar Data
argenx SE USD 371.14M 21.17M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
Biogen USD 514.3M 502.8M 2026-03
Genmab DKK 260M 199M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Incyte USD 344.17M 39.71M 2026-03
Merck EUR 474M 738M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.18B 118M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
UCB EUR 1.29B 571M 2025-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03